Junji Tanaka, Norina Tanaka, Yan-Hua Wang, Kenjiro Mitsuhashi, Michiko Ryuzaki, Yuki Iizuka, Aya Watanabe, Midori Ishiyama, Akihito Shinohara, Hiroshi Kazama, Shotaro Hagiwara, Kentaro Yoshinaga, Yumi Kougen, Hirohito Kobayashi, Hitoshi Kanno, Masayuki Shiseki. Phase I study of cellular therapy using ex vivo expanded natural killer cells from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients. haematol [Internet]. 2020Mar.31 [cited 2024Nov.23];105(4):e190-e193. Available from: https://haematologica.org/article/view/9363